Amazon GLP-1 remedy
Supply: Amazon Inc.
Amazon is pushing deeper into the booming weight reduction market, unveiling Tuesday a brand new program that goals to simplify entry to common GLP-1 remedies.
The corporate stated its main care arm, Amazon One Medical, is launching a GLP-1 administration program that integrates weight problems remedy into routine care. The providing combines digital and in-person visits, prescription administration and pharmacy achievement, positioning weight administration as a long-term persistent situation fairly than a one-off prescription.
“Offering prospects with quick, handy treatment entry and clear, clear pricing is integral to how Amazon Pharmacy is reworking the pharmacy expertise,” stated Tanvi Patel, vice chairman and basic supervisor of Amazon Pharmacy, within the firm’s press launch.
“By increasing entry to the newest GLP-1 drugs with upfront, clear pricing, we’re making it simpler for patrons to get the remedies their well being care suppliers prescribe and to remain on these drugs as a result of they’re delivered reliably on to sufferers,” Patel stated.
By means of Amazon Pharmacy, sufferers will be capable to entry drugs together with Novo Nordisk’s Wegovy in addition to newer oral GLP-1 choices. Insured pricing will begin as little as $25 monthly, Amazon stated. For cash-paying sufferers, oral medicine begin at $149 monthly, it stated.
Injectable remedies, together with Wegovy pictures and Eli Lilly’s Zepbound, start at $299 monthly when paid for with out insurance coverage, Amazon stated.
These costs are roughly in keeping with a lot of the present market.
However Amazon’s edge is in same-day supply and comfort because it seems to be to leverage its logistics community and shopper attain into one other nook of the medical system.
The corporate additionally stated it’ll supply on-demand prescription renewals, beginning at $29 for message session and $49 for video care. Amazon plans to broaden its same-day drug supply providing to 4,500 cities by the tip of 2026.
Shares of a number of firms tied to the weight problems drug growth moved decrease following Amazon’s Tuesday announcement, together with Hims & Hers Well being, Viking Therapeutics, Amgen and Septerna.